Title: Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.
Journal: Journal of medicinal chemistry 20120209
3070-86-8
7274-71-7
7766-37-2
6312-87-4
241132-67-2
13132-94-0
1375473-69-0 | methyl 3-(methoxymethyl)-3-methyloxirane-2-carboxylate | AA019SWA | MFCD21321621
1354953-68-6 | methyl 2-amino-5H,6H,7H-cyclopenta[b]pyridine-3-carboxylate | AA019T17 | MFCD20731205
1038713-54-0 | 3-Chloro-2-hydroxy-5-phenylbenzoic acid | AA019T5T | MFCD11203649
727719-96-2 | 1-[4-(aminomethyl)piperidin-1-yl]-2-phenylethan-1-one | AA019TA1 | MFCD10016306
1375474-56-8 | tert-butyl 6-methyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-4-carboxylate | AA019TGQ | MFCD21334172
1375474-31-9 | {[3-(1-methoxyethyl)-1,2,4-oxadiazol-5-yl]methyl}(methyl)amine | AA019TKV | MFCD21602696
1375474-34-2 | 3-(3-phenoxypropoxy)azetidine hydrochloride | AA019TP8 | MFCD21602747
1183360-25-9 | 4-[(3-amino-1H-1,2,4-triazol-1-yl)methyl]benzonitrile | AA019TU3 | MFCD12766716
1261508-23-9 | 3-bromo-2-isocyanatobenzonitrile | AA019TYT | MFCD18390810
756870-02-7 | 2-[(3-bromophenyl)methyl]-4-methylpentanoic acid | AA019U2N | MFCD12152857